JAN 28, 2020 4:00 PM PST

Protein complex discovered as first biomarker of PTSD

WRITTEN BY: Tara Fernandez

 

Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR) have identified a potential diagnostic biomarker; a protein complex found to be elevated amongst individuals suffering from post-traumatic stress disorder (PTSD).

Marked by crippling anxiety, nightmares and looping memories of the traumatic event, there are extremely few diagnostic or treatment options that work. Moreover, the prevalence of PTSD in the community is on the rise. Among U.S. military personnel alone, an estimated 2 percent have the condition after facing life-threatening, combat-related experiences. Likewise, victims of violence, assault, and natural disasters also contend with PTSD’s debilitating symptoms.

 

 

Managing PTSD usually involves a combination of cognitive-behavioral psychotherapy and medications, although even with these interventions, patient outcomes are disappointing.

In a breakthrough finding, the authors of the study, published in the Journal of Clinical Investigation, discovered that the Glucocorticoid Receptor-FKBP51 (GR-FKBP51) protein complex was substantially elevated in individuals with symptoms of PTSD. These differential levels could serve as a potential diagnostic biomarker.

The team’s lead, Professor Fang Liu from the University of Toronto said, “We believe this protein complex normally increases after severe stress, but in most cases, levels soon go back to baseline levels.”

“However, in those who develop PTSD, the protein complex remains persistently elevated, and so this could be a blood-based biomarker for PTSD as well as being a target for pharmacological treatment.”

On another promising note, the investigators tested a possible PTSD therapeutic in a mouse model of PTSD: an interfering peptide that blocks the effects of GR-FKBP51. By disrupting and shielding against the physiological and cognitive effects of excessive GR-FKBP51, this peptide blocker could even be applied as a preventative therapy in the wake of serious, traumatic events.

The next steps for the authors include further validation of their findings before kicking off clinical trials amongst survivors of PTSD.

 

 

Sources: ZME Science, The Journal of Clinical Investigation.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 03, 2021
Health & Medicine
The Challenges and Advantages of Direct PCR Amplification
MAY 03, 2021
The Challenges and Advantages of Direct PCR Amplification
  Testing for COVID-19 continues to be one of the most important tools in the global fight to slow and reduce the i ...
MAY 20, 2021
Clinical & Molecular DX
Gonorrhea Testing on the Go
MAY 20, 2021
Gonorrhea Testing on the Go
Forget lab-based tests—a new portable microfluidic device links to a mobile app, diagnosing gonorrhea in just 15 m ...
JUL 15, 2021
Clinical & Molecular DX
Childhood Lead Exposure Influences Personality in Adulthood
JUL 15, 2021
Childhood Lead Exposure Influences Personality in Adulthood
Exposure to toxic chemicals in childhood could have unlikely effects on personality, and behavioral traits in adulthood, ...
AUG 19, 2021
Clinical & Molecular DX
Biosensor Illuminates Growing Tumors and Healing Wounds
AUG 19, 2021
Biosensor Illuminates Growing Tumors and Healing Wounds
Cancerous tissues can be difficult to spot, particularly at the early stages. The malignant cells are sometimes indistin ...
AUG 23, 2021
Clinical & Molecular DX
Better Health Monitoring Protects Nursing Home Residents
AUG 23, 2021
Better Health Monitoring Protects Nursing Home Residents
Residents of nursing homes are particularly susceptible to health complications. Around half of all individuals residing ...
SEP 14, 2021
Clinical & Molecular DX
HIV Self-Test App Proves Promising
SEP 14, 2021
HIV Self-Test App Proves Promising
A new app allows users to self-test for HIV, which has proven to help positive patients get access to medical care and c ...
Loading Comments...